Medexus Pharmaceuticals (MDP.V) CEO and director Ken d’Entremont on specialty drugs (Ep 11) First Glance with Jody Vance Equity Guru January 11, 2021 Vancouver’s own Jody Vance speaks with Ken d’Entremont, Medexus Pharmaceuticals (MDP.V) CEO and director, to find out more about the company’s mandate of bringing established drugs approved in other countries to patients in Canada. Listen in! Related Posts Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Name * Email * Website Comment * Save my name, email, and website in this browser for the next time I comment.